INTEGRIS Cancer Institute of Oklahoma Proton Campus — Oklahoma City, Oklahoma

INTEGRIS Cancer Institute of Oklahoma Proton Campus is a clinical research site located in Oklahoma City, Oklahoma, United States 73142.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

INTEGRIS Cancer Institute of Oklahoma Proton Campus has participated in 2 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Calithera Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for INTEGRIS Cancer Institute of Oklahoma Proton Campus?

INTEGRIS Cancer Institute of Oklahoma Proton Campus has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has INTEGRIS Cancer Institute of Oklahoma Proton Campus conducted?

INTEGRIS Cancer Institute of Oklahoma Proton Campus has 2 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is INTEGRIS Cancer Institute of Oklahoma Proton Campus accredited by Crixeo Health?

INTEGRIS Cancer Institute of Oklahoma Proton Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about INTEGRIS Cancer Institute of Oklahoma Proton Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.